Robert P. Lyon
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 2%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 32
- HER2/EGFR in Cancer Research 29
- Peptidase Inhibition and Analysis 6
- Cancer Treatment and Pharmacology 5
- CAR-T cell therapy research 5
-
- Monoclonal and Polyclonal Antibodies Research 32
- Co-authors
- Peter D. Senter (20 shared papers)Jocelyn R. Setter (9 shared papers)Martha E. Anderson (13 shared papers)Joshua H. Hunter (7 shared papers)Svetlana O. Doronina (8 shared papers)William M. Atkins (5 shared papers)Patrick Burke (12 shared papers)Tim D. Bovee (5 shared papers)
- Journals
- Cancer Research (13 papers)Molecular Cancer Therapeutics (8 papers)Nature Biotechnology (3 papers)Biochemistry (3 papers)Bioconjugate Chemistry (2 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Robert P. Lyon
45 papers receiving 2.2k citations
Robert P. Lyon's Hit Papers
Peers
Comparison fields: 5 of 86
- Radiology, Nuclear Medicine and Imaging 1.4k
- Oncology 1.4k
- Immunology and Allergy 102
- Molecular Biology 984
- Biomaterials 176
Countries citing papers authored by Robert P. Lyon
This map shows the geographic impact of Robert P. Lyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert P. Lyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert P. Lyon more than expected).
Fields of papers citing papers by Robert P. Lyon
This network shows the impact of papers produced by Robert P. Lyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert P. Lyon. The network helps show where Robert P. Lyon may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert P. Lyon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index Hit paper breakdown → | 2015 | 390 |
| 2 | Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates Hit paper breakdown → | 2014 | 358 |
| 3 | 2013 | 291 | |
| 4 | 2016 | 231 | |
| 5 | 2016 | 110 | |
| 6 | 2001 | 87 | |
| 7 | 2011 | 78 | |
| 8 | 2008 | 73 | |
| 9 | 2019 | 64 | |
| 10 | 2008 | 60 | |
| 11 | 2016 | 56 | |
| 12 | 2020 | 52 | |
| 13 | 2018 | 47 | |
| 14 | 2016 | 45 | |
| 15 | 2018 | 43 | |
| 16 | 2015 | 37 | |
| 17 | 2005 | 35 | |
| 18 | 2018 | 32 | |
| 19 | 1999 | 31 | |
| 20 | 2003 | 30 |
About Robert P. Lyon
Robert P. Lyon is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology and Allergy and Organic Chemistry, having authored 45 papers that have together received 2.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (32 papers), HER2/EGFR in Cancer Research (29 papers), Cell Adhesion Molecules Research (10 papers), Peptidase Inhibition and Analysis (6 papers), Cancer Treatment and Pharmacology (5 papers), CAR-T cell therapy research (5 papers), Glycosylation and Glycoproteins Research (5 papers) and Glutathione Transferases and Polymorphisms (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.4k citations), Oncology (1.4k citations), Immunology and Allergy (102 citations), Molecular Biology (984 citations) and Biomaterials (176 citations). Robert P. Lyon has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Peter D. Senter, Jocelyn R. Setter, Martha E. Anderson, Joshua H. Hunter, Svetlana O. Doronina, William M. Atkins, Patrick Burke, Tim D. Bovee, Mechthild Jonas and Chris Leiske. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Nature Biotechnology, Biochemistry and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.